Flu Season: New data from the NHS shows rapid rise in flu cases across the UK, whilst across the world, china continues its battle against human metapneumovirus virus.
According to a new study, fenofibrate, a drug used to treat abnormal levels of fatty substances in the blood, could reduce COVID-19 infection by up to 70%.
Dr Tedros Ghebreyesus, WHO leader, asked richer countries in the Global North to wait before giving third COVID jabs - as the Global South is yet to hit 10% double-vaccinated, due to low vaccine supply.
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.
Abhishek Goel, CEO, Cactus Communications, addresses the economic and mental health fallout of the pandemic and how AI can improve engagement with employees and monitor their wellbeing.
A new clinical trial, funded by the UK government, will investigate the best gap between the first and second COVID-19 vaccine dose for pregnant women.
A study, published in the journal DNA Repair, finds that hydroxychloroquine (HCQ) is potentially toxic to mammals - the drug that was previously elevated to the status of miracle COVID cure in some circles.
France's Junior Minister for European Affairs, Clément Beaune, said that the price of COVID vaccines Pfizer and Moderna rose after being adapted for the Delta variant.
According to The Guardian, the NHS is concerned that 170,000 Moderna jabs will expire soon - as vaccine take-up in the 18-25 year old bracket slows down.
